Today: 9 June 2026
Analog Devices stock closes near a 52-week high after Barclays upgrade, with earnings next week
15 February 2026
2 mins read

Analog Devices stock closes near a 52-week high after Barclays upgrade, with earnings next week

New York, Feb 14, 2026, 17:42 (EST) — The session has ended.

  • Analog Devices finished Friday’s session at $337.10, up 1.73%, hovering just shy of its recent high.
  • Barclays bumped ADI up to “Overweight,” slapping on a $375 target. The call cites industrial exposure and PMIs as key drivers.
  • ADI’s fiscal first-quarter numbers land Feb. 18. U.S. markets are shut Monday for Presidents Day.

Analog Devices (ADI.O) finished Friday up 1.73% at $337.10, sticking close—within 2%—to its 52-week peak, and outpacing several rivals. Shares of Broadcom dropped 1.81%. Texas Instruments picked up 1.42%, while KLA gained 0.92%.

This is worth watching, with ADI set to deliver fiscal first-quarter earnings on Feb. 18—an event that stands out for investors closely watching the analog-chip space tied to the industrial cycle. ADI plans to release its results at 7:00 a.m. ET, followed by a conference call at 10:00 a.m. ET.

Macro moves haven’t let up. U.S. January CPI came in at 2.4% year-on-year—slightly missing the 2.5% mark economists had penciled in. Treasury yields dropped, with the market doubling down on rate-cut hopes into the long weekend, Reuters said. “It is a bit of good news as we head into the long holiday weekend,” said Tim Holland, chief investment officer at Orion. Reuters

Barclays’ Tom O’Malley bumped up Analog Devices to “Overweight” from “Equal Weight” and took his price target to $375, up from $315. “Overweight” signals he expects the stock to do better than others he covers. O’Malley pointed out ADI’s outsized industrial exposure—calling it the biggest in the analog category “by far”—and described it as a “quality name to own” with PMIs starting to rebound. TipRanks

The call landed just as the stock swung sharply with the broader market action. ADI slid 1.67% on Thursday, closing at $331.36 during a broad selloff. Volume that day ran above the recent norm. It bounced back the next session.

Semiconductors bounced back. The PHLX Semiconductor Index gained 0.66% Friday, recouping part of Thursday’s sharp 2.50% slide.

Semiconductor sentiment could stay volatile heading into next week. Shares of Applied Materials surged roughly 11% Friday, propelled by an upbeat forecast linked to AI-fueled demand. That rally spilled over to other chip-equipment players, giving a boost to Lam Research and KLA.

Traders miss out on a session—U.S. markets shut down Monday for Presidents Day, so it’s a compressed week before ADI’s numbers hit.

Analog Devices faces a straightforward but tough checklist: look for upticks in industrial demand, watch for any movement in how customers are working through inventories, and gauge if communications demand is picking up with cloud investment.

The PMI often comes up as a top scorecard in this conversation. It’s a business activity survey—generally, anything over 50 signals growth.

Still, as the share price climbs, so do expectations. Any hint of a softer outlook, or wording that implies the recovery might be fading, could easily knock down a stock trading this close to its highs.

Bigger market forces can easily overshadow individual company news. On Thursday, tech stocks slid, rattled by renewed concerns over AI disruption—a clear sign that investors’ risk tolerance remains shaky.

Feb. 18 brings ADI’s report and fresh guidance. That’s when the market figures out if the buying ahead of the print was smart positioning or simply overdone.

Stock Market Today

  • WisdomTree Launches Space Economy ETF Amid Rising Thematic Demand
    June 9, 2026, 10:37 AM EDT. WisdomTree has launched the WisdomTree Space Economy UCITS ETF (WSPC), targeting companies in space-related technologies and services, with a 0.50% expense ratio. The ETF, listed on multiple European exchanges, tracks an index focused on launches, commercial space, defence, and emerging tech. This reflects the shift from government-led space exploration to a commercial ecosystem, including satellite connectivity and climate monitoring. Investor interest in space tech is growing, highlighted by Seraphim Space Investment Trust's near 200% share rise. WisdomTree now manages $10.9 billion in thematic ETFs, with $3.3 billion net inflows in 2026, underscoring increasing demand for specialised thematic investment strategies.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
DraftKings stock price tumbles after 2026 outlook miss; what DKNG traders watch next
Previous Story

DraftKings stock price tumbles after 2026 outlook miss; what DKNG traders watch next

Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes
Next Story

Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes

Go toTop